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1. INTRODUCTION {#mpr1774-sec-0005}
===============

Outcome measurement (OM) is the assessment of the "effect on a patient\'s health status that is attributable to an intervention by a health professional or health service" (Andrews, Peters, & Teesson, [1994](#mpr1774-bib-0001){ref-type="ref"}, p. 3). An outcome is the end result of a provided health service that affects the health status and functioning of the patient treated, thus reflecting what happens to the patient "in terms of palliation, control of illness, cure, or rehabilitation" (Brook, Williams, & Avery, [1976](#mpr1774-bib-0009){ref-type="ref"}, p. 809). It focuses on the change and allows evaluation of both the services provided and the patients\' progress during treatment. In the late 1970s, a discussion regarding the necessity of OM in mental health services arose in the United States and spread internationally in the 1980s (Brook et al., [1976](#mpr1774-bib-0009){ref-type="ref"}; Erickson, [1975](#mpr1774-bib-0025){ref-type="ref"}; Lohr, [1988](#mpr1774-bib-0052){ref-type="ref"}; Slade, Thornicroft, & Glover, [1999](#mpr1774-bib-0071){ref-type="ref"}). Sutherland and Till ([1993](#mpr1774-bib-1074){ref-type="ref"}) identified three levels, at which OM might prove useful: micro (e.g., individual or clinical), meso (e.g., within an institution), and macro (e.g., governmental).

1.1. OM instruments {#mpr1774-sec-0006}
-------------------

OM instruments assess outcomes using either an external perspective (e.g., clinicians or relatives) or the patient\'s subjective perception, or both (Thornicroft & Slade, [2014](#mpr1774-bib-0074){ref-type="ref"}). They cover various domains, such as well‐being, global functioning, quality of life, physical or mental condition, satisfaction with the treatment, provided services, or their costs (Slade, [2002](#mpr1774-bib-0068){ref-type="ref"}; Thornicroft & Tansella, [2010](#mpr1774-bib-0075){ref-type="ref"}). Outcome measures can be symptom independent or targeted a specific group of mental diseases; they can focus on recovery or individual goals in the course of treatment (Thornicroft & Slade, [2014](#mpr1774-bib-0074){ref-type="ref"}).

Several instruments have been developed to measure outcomes. For example, the Health of the Nation Outcome Scales (Wing et al., [1998](#mpr1774-bib-0082){ref-type="ref"}) focuses upon the outcome of mental health treatments using an external perspective (clinicians). Because the external perspective is not always reliable and possibly biased, some authors recommend to integrate also the patient\'s perspective (Slade, [1996](#mpr1774-bib-0067){ref-type="ref"}; Slade, Leese, Taylor, & Thornicroft, [1999](#mpr1774-bib-0070){ref-type="ref"}). The Inventory of Interpersonal Problems (Horowitz, Rosenberg, Baer, Ureno, & Villasenor, [1988](#mpr1774-bib-0040){ref-type="ref"}) focuses on interpersonal problems causing psychological distress. Symptom dependent measures such as the Beck Depression Inventory (BDI‐II; Beck, Steer, & Brown, [1996](#mpr1774-bib-0005){ref-type="ref"}) can be used for assessment of the symptom severity in course of the therapies. Moreover, there are questionnaires measuring important constructs for outcome assessment, such as well‐being (e.g., Quality of Well‐Being Scale; Kaplan & Bush, [1982](#mpr1774-bib-0048){ref-type="ref"}), global functioning (e.g., Global Assessment Scale; Endicott, Spitzer, Fleiss, & Cohen, [1976](#mpr1774-bib-0024){ref-type="ref"}, or Work and Social Adjustment Scale; Mundt, Marks, Shear, & Greist, [2002](#mpr1774-bib-0060){ref-type="ref"}), and quality of life (e.g., Quality of Life Scale; Flanagan, [1978](#mpr1774-bib-0031){ref-type="ref"}).

1.2. The CORE‐OM {#mpr1774-sec-0007}
----------------

The present study focuses on the Clinical Outcome in Routine Evaluation--Outcome Measure (CORE‐OM; Barkham et al., [1998](#mpr1774-bib-0002){ref-type="ref"}). It concentrates on the areas mentioned above plus the patient\'s resources. If the CORE‐OM works the way it was designed, we would dispose of an instrument gathering a wide spectrum of information useful for assessing the treatment progress from the patient\'s perspective. Its development relied on a survey of mental health services in the United Kingdom, which revealed a lack of systematic information on patient\'s health status in pretreatment and posttreatment phases (Mellor‐Clark, Barkham, Connell, & Evans, [1999](#mpr1774-bib-0057){ref-type="ref"}). The CORE‐OM has been integrated into the British National Health System (Slade, [2010](#mpr1774-bib-0069){ref-type="ref"}).

1.3. Structure {#mpr1774-sec-0008}
--------------

The CORE‐OM contains 34 items split into to the four scales *well‐being* (four items), *problems/symptoms* (12 items), *functioning* (12 items), and *risk* (six items) using a five‐categorical response format (0 = *not at all*, 1 = *only occasionally*, 2 = *sometimes*, 3 = *often*, and 4 = *most or all the time*); eight items are inversely worded. According to the manual, the CORE‐OM is not restricted to specific diagnosis groups. The questionnaire is copyleft (i.e., it can be used free of charge), which fosters its broad application.

1.4. Evaluation {#mpr1774-sec-0009}
---------------

Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) evaluated the psychometric properties of the CORE‐OM using a clinical sample collected from 23 sites within the National Health Service, three university student counselling services, and a staff support service in the United Kingdom (*n* = 890; 60% female) and a nonclinical sample (*n* = 1,106; 54% female) of university students and staff as well as "a sample of convenience" (Evans et al., [2002](#mpr1774-bib-0026){ref-type="ref"}, p. 53; Lohr, [1999](#mpr1774-bib-0053){ref-type="ref"}) representing the "general population." Table [1](#mpr1774-tbl-0001){ref-type="table"} gives an overview about the results of psychometric analyses.

###### 

An overview of psychometric properties (reliability and validity) of the English CORE‐OM in accordance to Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"})

                         Method/instrument   Sample type           Well‐being   Problems   Functioning   Risk   Nonrisk items   Total score
  ---------------------- ------------------- ------------- ------- ------------ ---------- ------------- ------ --------------- -------------
  Reliability            Cronbach\'s *α*     Clinical      1,106   0.75         0.88       0.87          0.79   0.94            0.94
  Nonclinical            890                 0.77          0.90    0.86         0.79       0.94          0.94                   
  Test stability (*ρ*)   Student sample      43            0.88    0.87         0.87       0.64          0.91   0.90            
  Validity               BDI‐I               Clinical      251     0.77         0.78       0.78          0.59   0.84            0.85
  BDI‐II                 29                  0.79          0.74    0.78         0.32       0.83          0.81                   
  BSI                    97                  0.63          0.76    0.71         0.62       0.79          0.81                   
  SCL‐90                 34                  0.68          0.87    0.79         0.83       0.85          0.88                   
  GHQ                    69                  0.67          0.66    0.65         0.56       0.72          0.75                   
  GHQ‐A                  69                  0.43          0.60    0.44         0.30       0.56          0.55                   
  GHQ‐B                  69                  0.55          0.61    0.57         0.30       0.64          0.64                   
  GHQ‐C                  69                  0.60          0.52    0.60         0.44       0.62          0.63                   
  IIP‐32                 246                 0.48          0.58    0.65         0.45       0.64          0.65                   

*Note*. CORE‐OM: Clinical Outcome in Routine Evaluation--Outcome Measure; BDI‐I: Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, [1961](#mpr1774-bib-0006){ref-type="ref"}); BDI‐II: Beck Depression Inventory (Beck et al., [1996](#mpr1774-bib-0005){ref-type="ref"}); BSI: Brief Symptom Inventory (Derogatis & Melisaratos, [1983](#mpr1774-bib-0021){ref-type="ref"}); GHQ: General Health Questionnaire, 28‐item version (Goldberg & Hiller, [1979](#mpr1774-bib-0034){ref-type="ref"}); GHQ‐A: somatic symptoms; GHQ‐B: anxiety and insomnia; GHQ‐C: social dysfunction; IIP‐32: Inventory of Interpersonal Problems, 32‐item version (Barkham, Gillian, & Startup, [1996](#mpr1774-bib-1002){ref-type="ref"}); SCL‐90: Symptom Checklist‐90‐Revised (Derogatis, [1983](#mpr1774-bib-0020){ref-type="ref"}).

1.5. Translation {#mpr1774-sec-0010}
----------------

To foster international comparisons, Evans, Mellor‐Clark, Marginson, and Barkham ([2000](#mpr1774-bib-0028){ref-type="ref"}) and Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) called for translations into other languages by psychologists, psychiatrists, or psychotherapists. This process has to meet specific requirements defined by CORE System Trust (CST, [2011](#mpr1774-bib-0015){ref-type="ref"}, [2015](#mpr1774-bib-0016){ref-type="ref"}), requiring (a) forward translation, (b) a focus group discussing the translation, and (c) field testing and backward translation. One of the authors of the English CORE‐OM has to accompany the translational procedure. The CST ([2011](#mpr1774-bib-0015){ref-type="ref"}, [2015](#mpr1774-bib-0016){ref-type="ref"}) further specifies rules regarding the examination of the psychometric properties of the translations. The sample should be representative of the target population and comprise at least *N* = 100 for a clinical population, *N* = 40 for test--retest examination with the interval of 1 week to 1 month, and *N* = 200 for the clinical and *N* = 200 for the nonclinical population. Given that internal consistency and retest reliability can be considered sufficient, the CST guidelines further recommend assessing both the reliable change (Jacobson, Follette, & Revenstorf, [1984](#mpr1774-bib-0041){ref-type="ref"}) and clinical significant change (CSC; Jacobson & Truax, [1991](#mpr1774-bib-0042){ref-type="ref"}), the latter also termed "clinical reliability" (Evans, Margison, & Barkham, [1998](#mpr1774-bib-0027){ref-type="ref"}). The CST ([2011](#mpr1774-bib-0015){ref-type="ref"}) further recommends exploratory factor analysis (EFA) of the data. Interestingly, the CST ([2015](#mpr1774-bib-0016){ref-type="ref"}) relaxed the requirements by recommending sweepingly *N* = 100 for all samples and dropping the factor analysis from the list.

Barkham, Mellor‐Clark, Connell, and Cahill ([2006](#mpr1774-bib-0003){ref-type="ref"}) emphasized that the CORE‐OM focuses on "ethnic groups and European languages" (p. 9). Since its introduction in 1999, the CORE‐OM has been translated into 52 languages and dialects. According to the CST ([2018](#mpr1774-bib-0017){ref-type="ref"}), 23 translated versions of the CORE‐OM have been published and 29 translations were under development at the time of writing.

1.6. Rationale {#mpr1774-sec-0011}
--------------

According to the World Health Organization (WHO, [2018](#mpr1774-bib-0083){ref-type="ref"}) guidelines, a translation should be "conceptually equivalent in each of the target countries/cultures. (...) should be equally natural and acceptable and should practically perform in the same way. (...) A well‐established method to achieve this goal is to use forward‐translations and back‐translations." Thus, the WHO guidelines consider forward and backward translation sufficient to achieve "conceptual equality" of questionnaire translations. The translation process of the CORE‐OM followed these steps, so that from a WHO perspective, the translated versions of the CORE‐OM could be considered equivalent. However, if that claim holds, we should be able to provide empirical evidence for it---or reveal a lack thereof.

1.7. Objectives {#mpr1774-sec-0012}
---------------

The authors of the present study are not aware of a systematic comparison of the published translations of the CORE‐OM so far. Goldhahn, Shisha, Macdermid, and Goldhahn ([2013](#mpr1774-bib-0035){ref-type="ref"}) emphasized the importance of "appropriately translated instruments" for "international multicentre studies; or inclusion of people with different cultural backgrounds in national trials" (p. 591). Because the CORE‐OM will be used for international comparisons, we require empirical evidence that the translations can be considered equivalent from a psychometric point of view. Therefore, the present study compares all available studies of the translations of the CORE‐OM with respect to the reported psychometric properties considering the three major criteria (a) reliability (as reflected by internal consistency and retest stability), (b) validity (in terms of factorial structure, convergent, and discriminant validity), and (c) objectivity (in terms of application, evaluation, and interpretation of results). Only if these criteria are met to a sufficient extent can we recommend the various CORE‐OM versions for comparisons across countries with differing languages.

2. METHOD {#mpr1774-sec-0013}
=========

2.1. Study design {#mpr1774-sec-0014}
-----------------

The present study uses techniques applied in systematic reviews and meta‐analyses. Each article presenting a translation of the CORE‐OM serves as a primary study, the results of which will be summarised. We follow the guidelines for Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (Moher et al., [2015](#mpr1774-bib-0058){ref-type="ref"}). First, we provide a systematic review of studies of CORE‐OM translations with respect to the translational processes and psychometric analyses performed therein. Second, we conduct a meta‐analysis on the psychometric details with the primary focus on the three major criteria reliability, validity, and objectivity.

2.2. Data collection {#mpr1774-sec-0015}
--------------------

The official website of the CST ([2018](#mpr1774-bib-0017){ref-type="ref"}) lists available translations, contact information, and translations currently in progress. For each language listed there, we conducted a search on PsychINFO and PubMed using the search terms CORE‐OM AND psychom\* propert\* OR CORE‐OM AND translat\*; publication year from 1998 to 2018. Moreover, we also performed a Google scholar search using generic search terms, that is, "CORE‐OM" along with the respective language, for example, "German CORE‐OM". Authors, whose translations could not be found in these sources, were contacted via e‐mail. The target was to collect all articles presenting a translation of the CORE‐OM. To ensure the validity of findings, two persons (M. Z. and L. C. W.) performed the search independently of each other.

2.3. Information extraction {#mpr1774-sec-0016}
---------------------------

From each article, we extracted (a) data collection and sampling characteristics (sample type, recruiting of participants, and duration); (b) descriptive statistics of clinical and nonclinical samples (sample size, gender, and mean age); (c) reliability measures (Cronbach\'s *α*); test stability coefficients (Spearman and Pearson); and (d) details regarding the examination of the validity (factorial structure using EFA and confirmatory factor analysis \[CFA\] and correlations between the CORE‐OM and the SCL‐90 and the BDI‐II).

2.4. Analysis {#mpr1774-sec-0017}
-------------

Using a random‐effect meta‐analytical approach (DerSimonian & Laird, [1986](#mpr1774-bib-0022){ref-type="ref"}), we pooled Cronbach\'s *α*, the stability coefficients, and the correlations of the total scores of SCL‐90 and BDI‐II with the CORE‐OM total score, the modified total score (nonrisk items), and the scale scores. We calculated Cochran\'s *Q* (Cochran, [1950](#mpr1774-bib-0013){ref-type="ref"}) and *I* ^2^ and *H* ^2^ (Higgins & Thompson, [2002](#mpr1774-bib-0037){ref-type="ref"}) to assess the variation of studies outcomes. Further, we generated the diagnostic plot of Baujat, Mah, Pignon, and Hill ([2002](#mpr1774-bib-0004){ref-type="ref"}) and forest plots (Lewis & Clarke, [2001](#mpr1774-bib-0051){ref-type="ref"}) for visualisation of the results (see [Supporting Information](#mpr1774-supitem-0001){ref-type="supplementary-material"}). Regarding *I* ^2^, we follow the guideline of Quintana ([2015](#mpr1774-bib-0062){ref-type="ref"}), who suggests to consider up to 25% as low, 50% as moderate, and 75% and above as high variance between the studies. Using Cook\'s distance (Cook & Weisberg, [1982](#mpr1774-bib-0014){ref-type="ref"}), we identified the studies contributing most to heterogeneity. To detect possible explanations of observed differences in Cronbach\'s *α* and convergent validity coefficients, we performed a moderator analysis using (a) mean age of participants, (b) gender, and (c) sample type (inpatients, outpatients, and mixed samples) as covariates. For test stability coefficients, we disposed only of information on the sample type (community, students, and mixed samples), which was used as a moderator. Age and gender (proportion of females) were introduced as quantitative covariates, and sample type was dummy coded (*outpatients* as reference group for the internal consistency\'s analyses and *community* for test stability).

All analyses were performed with R (R Core Team, [2013](#mpr1774-bib-0063){ref-type="ref"}) applying the packages robumeta (Fisher, Tipton, & Zhipeng, [2017](#mpr1774-bib-0030){ref-type="ref"}) and metafor (Viechtbauer, [2010](#mpr1774-bib-0079){ref-type="ref"}). For better readability, references to specific studies are given in brackets throughout the text (full list in Table [2](#mpr1774-tbl-0002){ref-type="table"}).

###### 

An overview of all identified CORE‐OM publications

                                                                                                                                                                                                                                        Clinical                 Nonclinical                                                                                                                                                               
  --------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ----------------------- ------- --------- ------------------------ ------------- ------------------------------------------------- ---- ------- ------- ------- ------- ------- ---------------------------- ----------- ----- ----- ------- -------
  \[1\]                                                           Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"})                                                                    English                 Paper   En        890                      Out           Mental health services                            pp   530     344     ―       ―       1,106   University staff, students   pp          601   498   ―       ―
  \[2\]                                                           Bodinaku ([2014](#mpr1774-bib-0008){ref-type="ref"})                                                                        Albanian                PhD     En        209                      Out           Mental health centre                              pp   129     80      37      12.4    501     Community                    pp          249   252   40.2    15.1
  ‐[a](#mpr1774-note-0004){ref-type="fn"}                         Cartasso and Lemos ([2012](#mpr1774-bib-0012){ref-type="ref"})                                                              Argentinian             Paper   Esp       106                      Out           Psychiatric centre                                pp   75      31      ―       ―       ―       ―                            ―           ―     ―     ―       ―
  ‐[a](#mpr1774-note-0004){ref-type="fn"}                         Santana et al. ([2015](#mpr1774-bib-0065){ref-type="ref"})                                                                  Brazilian Portuguese    Paper   En        44                       Out           Trauma clinic                                     pp   20      24      43.2    14.1    55      Community                    pp          24    31    37      17.4
  \[3\]                                                           Jokic‐Begic, Korajlija, and Jurin ([2014](#mpr1774-bib-0044){ref-type="ref"})                                               Croatian                Paper   Hr        183                      In            Psychiatric hospital                              pp   108     75      47      10.68   425     Community                    pp          231   194   38.7    12.29
  \[4\]                                                           Juhová ([2015](#mpr1774-bib-0045){ref-type="ref"})                                                                          Czech                   PhD     Cz        175                      In            Psychiatric hospital                              pp   107     66      ―       ―       300     Students, community          pp/online   237   62    ―       ―
  \[5\]                                                           Meerding, van\'t Spijker, and van Riessen ([2012](#mpr1774-bib-0056){ref-type="ref"})                                       Dutch                   Paper   Nl        10,988                   Out           Different mental praxes                           pp   7,119   3,868   38.4    13      613     Community                    pp          314   298   47.7    17.7
  \[6\][b](#mpr1774-note-0006){ref-type="fn"}                     Juntunen, Piiparinen, Honkalampi, Inkinen, and Laitila ([2015](#mpr1774-bib-0047){ref-type="ref"})                          Finnish                 Paper   Fin       ―                        ―             ―                                                 ―    ―       ―       ―       ―       209     Community                    pp          114   95    43.2    16.2
  Honkalampi et al. ([2017](#mpr1774-bib-0039){ref-type="ref"})   Paper                                                                                                                       En                      201     In/out    Mental health services   pp            121                                               79   35.02   12.76                                                                                        
  \[7\]                                                           Sproll ([2011](#mpr1774-bib-0073){ref-type="ref"})                                                                          German                  Dipl    Ger       179                      Out           Psychotherapy ambulance, primary care ambulance   pp   103     76      36.6    12.6    197     Community                    pp          100   97    30.99   12.99
  \[8\]                                                           Kristjánsdóttir et al. ([2015](#mpr1774-bib-0049){ref-type="ref"})                                                          Icelandic               Paper   En        387                      Out           University hospital                               pp   317     70      38.05   ―       207     Students                     pp          136   71    22.7    ―
  \[9\]                                                           Palmieri et al. ([2009](#mpr1774-bib-0061){ref-type="ref"})                                                                 Italian                 Paper   En        647                      In/out        Psychotherapy ambulance                           pp   443     196     36      11.9    263     Students                     pp          192   71    25      5.8
  \[10\]                                                          Uji, Sakamoto, Adachi, and Kitamura ([2012](#mpr1774-bib-0078){ref-type="ref"})                                             Japanese                Paper   En        1,357                    In            Psychiatric hospitals                             pp   881     433     35      13.9    ―       Students, community          pp          ―     ―     ―       ―
  \[11\]                                                          Viliuniene et al. ([2012](#mpr1774-bib-0080){ref-type="ref"})                                                               Lithuanian              Paper   En        39                       Out           Psychotherapy ambulance                           pp   23      16      36.7    12.5    133     Students                     pp          93    37    20.8    0.7
  \[12\]                                                          Skre et al. ([2013](#mpr1774-bib-0066){ref-type="ref"})                                                                     Norwegian               Paper   En        527                      Out           Psychiatric centre                                pp   320     207     37.4    12.6    464     Students, community          pp          333   131   32.6    14.3
  ‐[a](#mpr1774-note-0004){ref-type="fn"}                         Sales, de Matos Moleiro, Evans, and Alves ([2012](#mpr1774-bib-0064){ref-type="ref"})                                       Portuguese              Paper   Port      ―                        ―             ―                                                 ―    ―       ―       ―       ―       ―       Students, community          pp          77    34    14      62
  \[13\]                                                          Zeldovich, Ivanov, Evans, and Andreas ([2014](#mpr1774-bib-0084){ref-type="ref"})                                           Russian                 Paper   Ru        159                      In            Psychiatric hospital                              pp   79      80      38.2    12.8    224     Students, community          pp/online   169   55    26.5    8.8
  \[14\]                                                          Gampe, Bieščad, Balúnová‐Labanicová, Timulák, and Evans ([2012](#mpr1774-bib-0032){ref-type="ref"})                         Slovak                  Paper   Slo       40                       In/out        Psychiatric hospital                              pp   20      20      36.13   ―       74      Students, community          pp          38    31    23.27   ―
  \[15\]                                                          Feixas et al. ([2012](#mpr1774-bib-0029){ref-type="ref"}) and Trujillo et al. ([2016](#mpr1774-bib-0077){ref-type="ref"})   Spanish                 Paper   Esp, en   192                      Out           Primary care ambulance                            pp   130     61      41.3    14.9    452     Students, community          pp          343   94    29.3    14.4
  \[16\]                                                          Elfström et al. ([2012](#mpr1774-bib-0023){ref-type="ref"})                                                                 Swedish                 Paper   En        619                      Out           Primary care ambulance                            pp   427     171     40.5    13      229     Students                     pp          126   103   27.5    8
  \[17\]                                                          Campbell and Young ([2016](#mpr1774-bib-0011){ref-type="ref"})                                                              Xhosa                   Paper   En        49                       Out           Mental health services for students               pp   ―       ―       ―       ―       194     Students                     pp          ―     ―     ―       ―
  \[18\]                                                          Campbell ([2011](#mpr1774-bib-0010){ref-type="ref"})                                                                        South African English   Paper   En        312                      Out           Mental health services for students               pp   232     80      20.6    ―       421     Students                     pp          256   165   21.23   ―

*Note*. In the text, we refer to the numbers in the first column. CORE‐OM: Clinical Outcome in Routine Evaluation--Outcome Measure; Pub: publication; Paper: published paper; PhD: PhD thesis; Dipl: diploma thesis; Lang: language of the publication. *N*: sample size; Type: sample type; pp: paper--pencil; Online: online survey; Collection: type of data collection; *M*: mean; *SD*: standard deviation; ―: information not available.

No psychometrics.

Psychometric properties of the Finnish CORE‐OM for the nonclinical sample originate from the publication Juntunen et al. ([2015](#mpr1774-bib-0047){ref-type="ref"}) and are, therefore, considered only once.

3. RESULTS {#mpr1774-sec-0018}
==========

3.1. Study selection {#mpr1774-sec-0019}
--------------------

From the 52 translations listed on the CST ([2018](#mpr1774-bib-0017){ref-type="ref"}), we could identify 26 publications covering 21 translations in the literature search. Two versions had more than one publication each: The Spanish version had one Spanish and one English paper, and the Finnish version had one master thesis and two publications in Finnish and English, respectively. If available, we chose the most recent available article for analysis, with a preference for published works over unpublished manuscripts. That way, 19 papers could be included in the quantitative analysis. Figure [1](#mpr1774-fig-0001){ref-type="fig"} shows the attrition diagram of the extraction process.

![A flow diagram depicting the selection process of the included in the analysis papers](MPR-28-e1774-g001){#mpr1774-fig-0001}

Some of these 19 articles did not report all information we sought for: 18 publications reported Cronbach\'s *α*, 12 coefficients for test stability examination, and five correlation analyses of the corresponding CORE‐OM with BDI‐II \[1, 2, 8, 14, 15\] and six with SCL‐90 \[1, 2, 6, 7, 14, 15\]. Four studies were not considered in our analyses for they used other instruments for validation (BDI‐I \[6\], Inventory of Interpersonal Problems‐32 \[7\], Beck Anxiety Inventory \[8\], and Brief Symptom Inventory \[13\]). Regarding dimensional analysis, we could identify five publications applying principal component analysis (PCA) and four studies provided a CFA, but results were not reported in sufficient detail. Due to the small number of studies applying EFA and CFA and the lack of comprehensive information on the fit statistics provided by those who did, we cannot perform a quantitative analysis and will, therefore, only summarise the results. For the same reason, no analysis of CSC could be performed. These findings were verified by two independent persons M. Z. and A. M. K.

3.2. Sample characteristics {#mpr1774-sec-0020}
---------------------------

From 21 translations, the clinical samples totalled to *N* = 17,303, with 11,184 (65%) female and 5,977 (35%) male respondents (142 missing); the mean age was 37.3 (*SD* = 12.9) years. All clinical samples were convenience samples covering both outpatients and inpatients of hospitals, primary care, day and psychotherapeutic services, private psychologists, and psychotherapists. All studies used the paper--pencil version of the respective CORE‐OM translation. Nonclinical samples consisted of *n* = 3,633 (61%) female and *n* = 2,319 (39%) male respondents. Gender was missing for *n* = 257 (1%) respondents. The mean age in the nonclinical samples was 30.4 (*SD* = 15.8). Three of the 21 studies tried to adapt the proportions in nonclinical samples using sociodemographic factors from population statistics of corresponding countries, regions, or cities. Bodinaku ([2014](#mpr1774-bib-0008){ref-type="ref"}) \[2\] used a random walk technique for data collection in Albania, only Meerding et al. ([2012](#mpr1774-bib-0056){ref-type="ref"}) \[5\] engaged a survey agency for recruiting of respondents in the Netherlands. Student samples were used in 14 studies as nonclinical samples, six of which as the only source of information. All studies used the paper--pencil version, and two had additionally an online survey. Reported durations for data collection were between half a year and 2 years. Table [2](#mpr1774-tbl-0002){ref-type="table"} gives an overview of field phases characteristics of the studies.

3.3. Internal consistency {#mpr1774-sec-0021}
-------------------------

In total, 18 studies calculated indices of internal consistency using the Cronbach\'s *α* for the total and subscale scores, 15 of them reported also values for the nonrisk total score (Table [3](#mpr1774-tbl-0003){ref-type="table"}). In addition to the total score for all 34 items, Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) suggested determining the total score for nonrisk items (28 items without six items from the *risk* scale) to investigate psychological distress, which will be included in our analyses. Table [6](#mpr1774-tbl-0006){ref-type="table"} summarizes the results of the psychometric analyses (see section Internal consistency \[Cronbach\'s *α*\]). The mean coefficients per scale (column 3) ranged from 0.93 (*total*) to 0.72 (*well‐being*). The *well‐being* and the *risk* scales showed lower values compared with the other scales and the total of items. All but the *problems* scale have significant heterogeneity values and a high amount (*I* ^2^ \> 75%) of between studies\' variance. The results of the outlier tests revealed two studies contributing most to variability in results \[3, 5\]. Moreover, the Croatian translation \[3\] contributed significantly to the mean Cronbach\'s *α* due to lower values in total score and total score of nonrisk items. Nevertheless, the values of internal consistency of the Croatian CORE‐OM were still acceptable with ${\overline{\alpha}}_{\textit{total}}\ $ = 0.86, confidence interval (CI) \[0.82, 0.89\] and ${\overline{\alpha}}_{\textit{total} - R}$ = 0.84, CI \[0.79, 0.88\]. The Dutch translation \[5\] influenced significantly the mean Cronbach\'s *α* of the scale *problems* with ${\overline{\alpha}}_{P}$ = 0.88, CI \[0.88, 0.88\].

###### 

Reliability of the CORE‐OM translations

           Reliability                                                                                                                        
  -------- ------------- ------ ------ ------ ------ ------ ----- --------------------- -------------- --- ------ ------ ------ ------ ------ ------
  \[1\]    0.75          0.88   0.87   0.79   0.94   0.94   43    Students              ―              S   0.88   0.87   0.87   0.64   0.90   0.91
  \[2\]    0.60          0.89   0.78   0.86   0.92   0.91   104   Community             7d             ―   0.69   0.70   0.78   0.48   0.80   0.81
  \[3\]    0.58          0.92   0.86   0.84   0.86   0.84   78    Community             Twice a week   P   0.77   0.83   0.91   0.58   0.88   0.88
  \[4\]    0.74          0.90   0.80   0.78   0.93   0.93   71    Students              7d             P   0.60   0.71   0.65   0.50   0.70   0.70
  \[5\]    0.75          0.88   0.84   0.72   0.94   0.93   ―     ―                     ―              ―   ―      ―      ―      ―      ―      ―
  \[6\]    0.77          0.89   0.85   0.78   0.94   0.94   ―     ―                     ―              ―   ―      ―      ―      ―      ―      ―
  \[7\]    0.71          0.89   0.79   0.80   0.93   0.92   55    Students              7d             S   0.74   0.82   0.63   0.43   0.83   0.82
  \[8\]    0.79          0.87   0.87   0.66   0.94   0.94   204   Students              2w             S   0.75   0.77   0.75   0.48   0.80   0.71
  \[9\]    0.71          0.87   0.77   0.77   0.92   0.91   ―     ―                     ―              ―   ―      ―      ―      ―      ―      ―
  \[10\]   0.68          0.89   0.81   0.83   0.94   ―      ―     Patients              4w             ―   0.67   0.82   0.72   0.66   0.85   ―
  \[11\]   0.81          0.86   0.82   0.67   0.93   ―      57    Students              7d             S   0.68   0.72   0.77   0.60   0.78   0.79
  \[12\]   0.70          0.87   0.84   0.81   0.94   0.93   81    Students              2w             S   0.63   0.69   0.70   0.35   0.76   0.76
  \[13\]   0.63          0.88   0.76   0.72   0.92   0.91   14    Patients              7d             S   0.90   0.57   0.81   0.18   0.76   ―
  \[14\]   0.67          0.88   0.77   0.85   0.93   0.92   67    Students, community   2w             S   0.70   0.66   0.70   0.56   0.75   0.75
  \[15\]   0.81          0.90   0.85   0.77   0.94   0.94   78    Students, community   2w+            S   0.76   0.85   0.79   0.45   0.87   0.87
  \[16\]   0.76          0.88   0.85   0.76   0.94   0.93   70    Students              2w+            S   0.80   0.80   0.81   0.64   0.85   0.86
  \[17\]   0.64          0.86   0.80   0.71   0.93   ―      ―     ―                     ―              ―   ―      ―      ―      ―      ―      ―
  \[18\]   0.76          0.89   0.84   0.73   0.94   .94    ―     ―                     ―              ―   ―      ―      ―      ―      ―      ―

*Note*. In the text, we refer to the numbers in the first column. CORE‐OM: Clinical Outcome in Routine Evaluation--Outcome Measure; No.: number for indication in text; W: well‐being; P: problems; F: functioning; R: risk; T: total score; ‐R: total score for nonrisk items; *N*: sample size; Type: sample type; Timespan: retest period in days (d) and weeks (w); Coef: coefficient (S: Spearman\'s *ρ*, P: Pearson\'s *r*); ―: information not available.

3.4. Test stability {#mpr1774-sec-0022}
-------------------

The shortest retest period was twice within 1 week \[3\]. The other retest periods were 1 week \[2, 4, 7, 11, 13\], 2 weeks or more \[15, 16\], and 1 month \[10\]. Six studies lacked information on retest periods, five papers provided no test stability analyses; seven studies used a student sample for retesting, two studies used community samples, and two used clinical samples for assessing test stability. We found two papers with a mixed sample of students and community members. The pooled test stability coefficients (see Table [6](#mpr1774-tbl-0006){ref-type="table"}, section Test--retest reliability \[Spearman\'s *ρ*\]) ranged from $\overline{\rho}$ = 0.51 (*risk*) to $\overline{\rho}$ = 0.82 (*total*). The *risk* scale showed generally a low test stability and low heterogeneity between the studies; *well‐being*, *problems*, *functioning*, and the total score as well as the total score of nonrisk items ranged from *I* ^2^ = 48% to *I* ^2^ = 72%. The Croatian CORE‐OM \[3\] influenced significantly the pooled results of the *functioning* scale.

3.5. Factorial structure {#mpr1774-sec-0023}
------------------------

Table [4](#mpr1774-tbl-0004){ref-type="table"} shows results regarding the factorial structure of the CORE‐OM translations. None of the studies applying factor analysis could replicate the intended four‐factor structure of the instrument. Eight studies \[1, 2, 4, 6, 7, 9, 11, 12\] applied a PCA like Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}), four of which favoured three major components. The results were largely declared comparable with those of Evans et al., finding in almost all analyses a positively formulated domain measuring strengths, a negatively formulated domain measuring weaknesses, and the set of risk items. One study \[2\] suggested either a one‐factorial or a two‐factorial solution to describe their data adequately.

###### 

Factorial structure of the CORE‐OM translations

           Factorial structure                                                                                                                 
  -------- --------------------- ------------ ----------- ------------------------------ ------- --------- ----- ------ ---------------------- ------
  \[1\]    C, NC                 Oblique      3           POS, NEG, RISK                 ―       ―         ―     ―      ―                      ―
  \[2\]    C, NC                 Orthogonal   Uncertain   One global scale solution      ―       ―         ―     ―      ―                      ―
  \[3\]    ―                     ―            ―           ―                              NC      1,641.1   509   0.80   0.07 \[―, ―\]          0.80
  \[4\]    C, NC                 Oblimin      3           POS, NEG, RISK                 ―       ―         ―     ―      ―                      ―
  \[5\]    ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[6\]    NC                    Oblimin      3           POS, NEG, RISK                 ―       ―         ―     ―      ―                      ―
  \[7\]    C, NC                 Oblique      3           POS, NEG, RISK                 ―       ―         ―     ―      ―                      ―
  \[8\]    ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[9\]    C                     ―            3           ―                              ―       ―         ―     ―      ―                      ―
  \[10\]   ―                     ―            ―           ―                              C       ―         ―     0.88   0.06                   ―
  \[11\]   C, NC                 Oblimin      3           ―                              ―       ―         ―     ―      ―                      ―
  \[12\]   C, NC                 Promax       2           Psychological distress, risk   NC      1,854.7   521   ―      0.08 \[―, ―\]          0.94
  \[13\]   ―                     ―            ―           ―                              C, NC   3,964.2   561   ―      0.057 \[0.05, 0.06\]   0.81
  \[14\]   ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[15\]   ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[16\]   ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[17\]   ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―
  \[18\]   ―                     ―            ―           ―                              ―       ―         ―     ―      ―                      ―

*Note*. In the text, we refer to the numbers in the first column. CORE‐OM: Clinical Outcome in Routine Evaluation--Outcome Measure; No.: number for indication in text; Sample: C: clinical; NC: nonclinical; rotation: method to perform the factor extraction; components: number of extracted components; factors: contextual meaning of extracted factors; POS: positively worded items; NEG: negatively worded items; RISK: risk items; *χ* ^2^: Chi‐square value; *df*: degrees of freedom; GFI: goodness of fit index; RMSEA: root mean square error of approximation; CI: confidence interval; CFI: comparative fit index; ―: information not available.

The four studies \[3, 10, 12, 13\] applying a CFA to assess the adequacy of the four‐factorial structure of Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) reported generally rather moderate results (Table [4](#mpr1774-tbl-0004){ref-type="table"}). None of the studies applying a CFA found the four‐factorial structure to describe the data best.

3.6. Convergent validity {#mpr1774-sec-0024}
------------------------

Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) correlated the English CORE‐OM with well‐established instruments. However, these instruments are not available in all target languages; thus, only nine studies deal with convergent validity. In total, six studies compared the CORE‐OM with the SCL‐90 and five with the BDI‐II. Table [5](#mpr1774-tbl-0005){ref-type="table"} summarizes coefficients resulted from single studies, and Table [6](#mpr1774-tbl-0006){ref-type="table"} (lower part) shows the results of the validity analyses. The pooled correlation coefficients of the SCL‐90 total score and the four scales ranged from $\overline{r}$ = 0.61 (*risk*) to $\overline{r}$ =0.82 (*total*).

###### 

Convergent validity of the CORE‐OM translations

  Convergent validity                                                                                                         
  --------------------- ---- ----- ------ ------ ------ ------ ------ ------ -- ---- ----- ------ ------ ------ ------ ------ ------
  \[1\]                 ++   29    0.79   0.74   0.78   0.32   0.81   0.83      ++   34    0.68   0.87   0.79   0.83   0.88   0.85
  \[2\]                 ++   209   0.68   0.76   0.71   0.57   0.84   0.84      ++   209   0.57   0.77   0.64   0.66   0.82   0.79
  \[3\]                 ++   ―     ―      ―      ―      ―      0.79   ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[4\]                 −    ―     ―      ―      ―      ―      ―      ―         +−   ―     0.71   0.81   0.71   0.56   0.84   0.83
  \[5\]                 +−   ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[6\]                 +−   ―     ―      ―      ―      ―      ―      ―         ++   201   0.67   0.83   0.73   0.57   0.81   0.82
  \[7\]                 +−   ―     ―      ―      ―      ―      ―      ―         ++   135   0.71   0.85   0.77   0.58   0.86   0.86
  \[8\]                 ++   577   0.78   0.78   0.79   0.52   0.85   0.82      −    ―     ―      ―      ―      ―      ―      ―
  \[9\]                 −    ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[10\]                +−   ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[11\]                +−   ―     ―      ―      ―      ―      ―      ―         −    ―     ―      ―      ―      ―      ―      ―
  \[12\]                +−   ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[13\]                +−   ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[14\]                ++   40    0.79   0.77   0.76   0.64   0.87   0.84      ++   40    0.79   0.76   0.73   0.58   0.83   0.84
  \[15\]                ++   162   0.79   0.80   0.74   0.48   0.83   0.83      ++   155   0.70   0.77   0.72   0.46   0.79   0.79
  \[16\]                +−   ―     ―      ―      ―      ―      ―      ―         +−   ―     ―      ―      ―      ―      ―      ―
  \[17\]                +−   ―     ―      ―      ―      ―      ―      ―         −    ―     ―      ―      ―      ―      ―      ―
  \[18\]                +−   ―     ―      ―      ―      ―      ―      ―         −    ―     ―      ―      ―      ―      ―      ―

*Note*. In the text, we refer to the numbers in the first column. CORE‐OM: Clinical Outcome in Routine Evaluation--Outcome Measure; A/U: indicates whether a translation of the Beck Depression Inventory‐II (BDI‐II) or the Symptom Checklist‐90 (SCL‐90) is available (A) or not (U) in the respective language and whether it has been used; ++: exists and used; +−: exists and not used; −−: does not exist or has been established after publication of respective study. No.: number for indication in text; *N*: sample size; W: well‐being; P: problems; F: functioning; R: risk; T: total score; ‐R: total score for nonrisk items; ―: information not available.

###### 

Results of heterogeneity tests

  Scale                                        No. of items   *α*    *ρ*    *r*    CI \[lower, upper\]   *Q*      *df*   *p*       *I* ^2^ (%)   *H* ^2^   Papers contributing to differences
  -------------------------------------------- -------------- ------ ------ ------ --------------------- -------- ------ --------- ------------- --------- ------------------------------------
  Internal consistency (Cronbach\'s *α*)                                                                                                                   
  Total score                                  34             0.93                 \[0.93, 0.94\]        56.73    17     \<0.001   81.26         5.34      \[3\]
  Nonrisk items                                28             0.92                 \[0.92, 0.94\]        64.84    14     \<0.001   88.24         8.50      \[3\]
  Well‐being                                   4              0.72                 \[0.69, 0.75\]        86.20    17     \<0.001   87.33         7.90      ―
  Problems                                     12             0.88                 \[0.88, 0.89\]        19.08    17     0.32      6.25          1.07      \[5\]
  Functioning                                  12             0.83                 \[0.81, 0.84\]        76.83    17     \<0.001   83.44         6.04      ―
  Risk                                         6              0.77                 \[0.74, 0.80\]        186.64   17     \<0.001   88.94         9.04      ―
  Test--retest reliability (Spearman\'s *ρ*)                                                                                                               
  Total score                                  34                    0.82          \[0.78, 0.85\]        22.07    11     0.02      52.44         2.10      ―
  Nonrisk items                                28                    0.81          \[0.77, 0.85\]        34.53    10     \<0.001   69.93         3.33      ―
  Well‐being                                   4                     0.74          \[0.69, 0.78\]        22.42    11     0.02      48.56         1.94      ―
  Problems                                     12                    0.77          \[0.72, 0.81\]        22.93    11     0.02      52.94         2.12      ―
  Functioning                                  12                    0.78          \[0.72, 0.82\]        36.25    11     \<0.001   72.01         0.57      \[3\]
  Risk                                         6                     0.51          \[0.46, 0.55\]        12.18    11     0.35      0.01          1.00      ―
  Convergent validity (SCL‐90)                                                                                                                             
  Total score                                  34                           0.82   \[0.80, 0.84\]        5.20     5      0.39      0.81          1.01      \[7\]
  Nonrisk items                                28                           0.81   \[0.80, 0.84\]        5.50     5      0.36      19.88         1.25      \[7\]
  Well‐being                                   4                            0.68   \[0.62, 0.73\]        9.24     5      0.1       46.48         1.87      \[2\]
  Problems                                     12                           0.81   \[0.77, 0.83\]        8.89     5      0.11      44.10         1.79      ―
  Functioning                                  12                           0.72   \[0.67, 0.76\]        7.17     5      0.21      36.58         1.58      \[2\]
  Risk                                         6                            0.61   \[0.51, 0.69\]        15.96    5      0.01      72.61         3.65      \[1\]
  Convergent validity (BDI‐II)                                                                                                                             
  Total score                                  34                           0.84   \[0.82, 0.86\]        1.21     4      0.88      0.00          1.00      ―
  Nonrisk items                                28                           0.83   \[0.81, 0.85\]        0.61     4      0.96      0.00          1.00      ―
  Well‐being                                   4                            0.76   \[0.71, 0.81\]        7.90     4      0.1       52.90         2.12      \[2\]
  Problems                                     12                           0.78   \[0.75, 0.80\]        1.17     4      0.88      0.00          1.00      ---
  Functioning                                  12                           0.76   \[0.71, 0.79\]        4.94     4      0.29      34.67         1.53      \[2, 8\]
  Risk                                         6                            0.53   \[0.47, 0.57\]        4.22     4      0.38      0.02          1.00      ―

*Note*. BDI‐II: Beck Depression Inventory‐II; SCL‐90: Symptom Checklist‐90; CI: confidence interval \[lower, upper\]; *Q*: Cochran\'s *Q*; *df*: degrees of freedom; *p*: *p* value; *I* ^2^ and *H* ^2^: heterogeneity coefficients; ―: none.

All but the *problems* scale showed nonsignificant heterogeneity tests for both SCL‐90 and BDI‐II. Nevertheless, some studies showed a major influence on the variability between the studies (see Table [6](#mpr1774-tbl-0006){ref-type="table"}, section Convergent validity \[SCL‐90\]). The German CORE‐OM \[7\] had a significant effect on the score for nonrisk items; the Albanian CORE‐OM \[2\] contributed significantly to differences in variability between the studies in the scales *well‐being* and *functioning*; and the results of the English CORE‐OM \[1\] influence significantly the variability of the validity coefficients in the scale *risk* with $\overline{r}$ = 0.83, CI \[0.68, 0.91\].

The correlation coefficients of the CORE‐OM scales with the total score of the BDI‐II (see Table [6](#mpr1774-tbl-0006){ref-type="table"}, section Convergent validity \[BDI‐II\]) ranged from $\overline{r}$ = 0.53 (*risk*) to $\overline{r}$ = 0.84 (*total*). The heterogeneity coefficients varied from *I* ^2^ = 0% (*total*, *nonrisk items*, and *problems*) to *I* ^2^ = 52.9% (*well‐being*). None of the results were significant. The Icelandic CORE‐OM \[8\] contributed to the findings in the *functioning* scale. The Albanian CORE‐OM \[2\] influenced the pooled correlation coefficients of the *well‐being* and *functioning* scales.

3.7. Moderator analysis {#mpr1774-sec-0025}
-----------------------

We found a moderating effect of the sample type upon Cronbach\'s *α*: The inpatient studies showed significantly lower internal consistency than the outpatient samples with respect to the total score, the nonrisk items, the *well‐being* scale, and the *problems* scale (see Table [7](#mpr1774-tbl-0007){ref-type="table"}). The coefficients in mixed samples did not differ significantly from the outpatient samples. None of the other moderator analyses revealed significant effects; therefore, they will not be reported in detail.

###### 

Results of the moderator analysis for Cronbach\'s *α* by sample type

  Cronbach\'s *α*                                                                 
  ----------------- ---- ------ --- ------ ------- ------- ------ ------- ------- ------
  Total score       18   4.30   2   0.12   −0.12   −2.02   0.04   −0.06   −0.89   0.38
  Nonrisk items     15   7.45   2   0.02   −0.21   −2.72   0.01   −0.06   −0.80   0.42
  Well‐being        18   5.51   2   0.06   −0.16   −2.34   0.02   −0.30   −0.38   0.71
  Problems          18   7.17   2   0.03   0.06    2.55    0.01   −0.02   −0.61   0.54
  Functioning       18   3.94   2   0.14   −0.09   −1.50   0.13   −0.12   −1.60   0.11
  Risk              18   1.57   2   0.46   0.09    1.18    0.24   0.07    0.69    0.49

*Note*. *k*: number of studies; *Q* ~M~: empirical *Q* value for moderator analysis; *df*: degrees of freedom; *p*: *p* value; *β*: regression coefficient; *z*: *z* value.

Compared with the outpatient sample.

3.8. Objectivity {#mpr1774-sec-0026}
----------------

The objectivity is difficult to evaluate in the face of the specificities of the target languages. All the versions of the CORE‐OM have the same appearance (a two‐sided A4 paper) with some slight optical differences (font type and size must be chosen from a list of given fonts). The head of the questionnaire containing sociodemographic data, treatment setting (beginning/follow‐up/end of the treatment), and the instructions is a part of the translation process and should also be discussed in the focus group. On the bottom of the back page, there is space to provide calculation of the scale means and the sum of the total score as well as the total score of nonrisk items. The instructions at the top support comparability across test coordinators. The instructions do not provide specific details regarding the interpretation of the results. The manual of the English CORE‐OM contains cut‐off points indicating the CSC. To allow for comparing different versions of the CORE‐OM, we need standardized scores, norm tables, and reference values for CSC (split by gender, age, or other relevant factors), which did not appear in the reviewed studies.

4. DISCUSSION {#mpr1774-sec-0027}
=============

4.1. Summary {#mpr1774-sec-0028}
------------

The present study compared systematically 21 translations of the CORE‐OM applying methods of systematic review and meta‐analysis. The research focussed on the comparability of the translations with respect to psychometric properties (especially reliability, validity, and objectivity). Our results show that the different versions of the CORE‐OM are largely comparable from a psychometric point of view and adequately reflect the English CORE‐OM. Despite a certain heterogeneity in data collection, sample sizes, and composition of the samples, the international versions of the CORE‐OM provide similar results of psychometric analyses regarding all criteria.

We identified six studies contributing significantly to internal consistency, retest reliability, and convergent validity, four of which in a positive direction and two (Croatia and Albania) showed significantly lower values in internal consistency and convergent validity, respectively. However, the internal consistency of the Croatian version was still above 0.80 and therefore satisfactory. In contrast, the Albanian *well‐being* and *functioning* scales had significantly and severely lower correlations with both external criteria (SCL‐90 and BDI‐II). This may be due to poor translation of the CORE‐OM, poor translation of the external criteria, inappropriate samples, or a specific attitude towards the well‐being and functioning constructs in the Albanian context. This should be pursued further in targeted studies.

The CORE‐OM was developed for outpatients (Barkham et al., [1998](#mpr1774-bib-0002){ref-type="ref"}). Because some studies collected inpatient data as well, we could compare the sample types in a moderator analysis. The internal consistency of inpatient samples was significantly lower than that of the outpatient samples; that is, the CORE‐OM performs better in the sample type it has been developed for. Hence, it should be used cautiously in inpatient settings, particularly in multicentre studies.

4.2. Reported analyses {#mpr1774-sec-0029}
----------------------

Almost all of the 21 studies (18) analysed internal consistency, and 13 assessed retest reliability. Only nine translations performed a validation using external measures such as BDI‐II and SCL‐90, although these two instruments are available in almost all target languages (see Table [4](#mpr1774-tbl-0004){ref-type="table"}). Likewise, the examination of the factorial validity was seldom carried out (7 PCA; 4 CFA). Therefore, factorial validity is difficult to evaluate. This may be due to the fact that the current translation guidelines (CST, [2015](#mpr1774-bib-0016){ref-type="ref"}) do not provide any details regarding the assessment of validity, which we would consider a worthwhile extension.

4.3. Sampling {#mpr1774-sec-0030}
-------------

Most of the samples were convenience samples for both clinical and nonclinical populations. Additionally, half of the studies assessing stability used student samples. Therefore, a generalization of these results is only possible with great caution, if at all.

4.4. Factorial structure {#mpr1774-sec-0031}
------------------------

None of the studies---including Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"})---could replicate the originally proposed four‐factorial structure of the CORE‐OM. Rather, the majority of the studies suggested that the 34 items represent a three‐factorial latent structure: positively worded items (assessing strengths), negatively worded items (assessing disabilities and distress), and the items of the *risk* scale. These findings are in line with former results regarding the factorial structure of the English CORE‐OM: Even the PCA of Evans et al. suggested a three‐factor solution. Lyne, Barrett, Evans, and Barkham ([2006](#mpr1774-bib-0055){ref-type="ref"}) suggested a two‐factorial structure (risk and psychological distress), recommending to use the risk items as a separate indicator of risky and self‐harming behaviour, but only by professionals. Handscomb, Hall, Hoare, and Shorter ([2016](#mpr1774-bib-0036){ref-type="ref"}) applied a CFA in a sample of tinnitus patients. They estimated 10 different model variants derived from previous studies on the CORE‐OM, finding also the poorest fit for the original four‐factorial solution and the best fit for the model containing negative, positive, and risk factors (i.e., the one that had already been identified by Evans et al., [2002](#mpr1774-bib-0026){ref-type="ref"}). Nevertheless, the questionnaire remained unaltered with respect to both number of items and scoring. Because the translated versions of the instrument have adopted this deficiency, we see a clear need for further research on the factorial structure and scoring of the CORE‐OM.

4.5. The *risk* scale {#mpr1774-sec-0032}
---------------------

The results indicate severe problems of the *risk* scale. The risk construct itself seems to function poorly in the selected clinical population across all countries. We have to assume that patients treated in an outpatient setting (for which the CORE‐OM has been designed) have already reached a certain degree of stability and are, therefore, not acutely at risk. None of the studies analysed here reported information on medical care for patients.

Hence, this scale seems applicable rather in an (inpatient) psychiatric setting, for example, shortly after admission and at the end of the stay, to detect possible changes. The psychometric properties of the *risk* scale in studies using inpatient samples (i.e., Croatian, Czech, Russian, and Slovak CORE‐OM) did not differ significantly from the studies using outpatients. Therefore, the *risk* scale requires further detailed research. Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}) have already suggested evaluating the total score without considering risk items, and the present research indicates again that this calculation approach should be pursued further. For example, studies involving patients with potentially harmful behaviour (e.g., drugs or substance abuse, psychoses, and depression) could clarify the mediocre results of this scale.

4.6. Independence with respect to diagnostic groups {#mpr1774-sec-0033}
---------------------------------------------------

Evans et al. ([2000](#mpr1774-bib-0028){ref-type="ref"}) considered the CORE‐OM suitable for all diagnostic groups (p. 253), which seems questionable in the light of our empirical results. There are some publications on special disorder groups investigating the psychometric properties of the CORE‐OM, such as eating disorder (Jenkins & Turner, [2014](#mpr1774-bib-0043){ref-type="ref"}) or emotional distress in people with tinnitus (Handscomb et al., [2016](#mpr1774-bib-0036){ref-type="ref"}). But we could not identify studies dedicated to the applicability of the CORE‐OM to patients with personality disorder or psychoses.

4.7. Reporting standards {#mpr1774-sec-0034}
------------------------

Our review showed also the need for more specific guidelines for reporting the results of psychometric analyses. The current CST ([2015](#mpr1774-bib-0016){ref-type="ref"}) guidelines specify detailed steps regarding the translation processes, so that translating authors are subject to highly standardised procedures. In contrast, no specific guidelines exist regarding mandatory analyses and reporting standards. It should be determined which methods are suitable for recording the respective psychometric properties (e.g., whether Spearman or Pearson correlation coefficients should be preferred for assessing the test stability). The sample sizes should be supported by a power analysis to clarify the consequences of noncompliance with regulations. The sampling requires clear presentation (see Lounsbury, Gibson, & Saudargas, [2006](#mpr1774-bib-0054){ref-type="ref"}, discussing the consequences of using student samples). Furthermore, a standardized presentation of the results would increase the comparability of studies. Our results show further that the studies dealt only marginally with the calculation of both the CSC and the reliable change. Because the CORE‐OM is primarily suitable for measuring change, the necessity of both indices seems highly indicated.

4.8. Methodology {#mpr1774-sec-0035}
----------------

We consider the chosen procedure appropriate for comparing the various translations. Gilbody, Richards, Brealey, and Hewitt ([2007](#mpr1774-bib-0033){ref-type="ref"}) conducted a similar analysis using international versions of the Patient Health Questionnaire (Spitzer, Kroenke, & Williams, [1999](#mpr1774-bib-0072){ref-type="ref"}) and Patient Health Questionnaire‐9 (Kroenke, Spitzer, & Williams, [2001](#mpr1774-bib-0050){ref-type="ref"}). This technique has proven successful for comparative studies on questionnaires and can, therefore, be considered as a standard procedure for multiple language translation.

4.9. Conclusion {#mpr1774-sec-0036}
---------------

The question, whether different translations of the CORE‐OM can be treated as one and the same instrument, could therefore be answered with "yes." However, reservations exist regarding the quality of the original (English) CORE‐OM, especially regarding the factorial structure. All translations applied the original factorial structure thus adopting its weaknesses as well. Therefore, we recommend a revision of the instrument in this regard. Keeping in mind that we dispose already of numerous follow‐up studies probing various alternative models, it is interesting to note that none of these results has so far found its way into the CORE‐OM. A very promising candidate was the approach of Lyne et al. ([2006](#mpr1774-bib-0055){ref-type="ref"}). The authors used a "nested factors first‐order general factor model with four residualized latents (...) and with two method latents of positively and negatively worded items" (p. 195). However, this complex model would not allow for a straightforward scoring required in a clinical daily routine. Another promising candidate would be the three‐factorial model of Evans et al. ([2002](#mpr1774-bib-0026){ref-type="ref"}), which deserved a closer inspection, possibly involving item response theory models (e.g., de Ayala, [2009](#mpr1774-bib-0019){ref-type="ref"}).

Our results show further that the instrument performs better with outpatient samples, which has to be considered when using the CORE‐OM in multicentre studies. Finally, international guidelines for the reporting on translation and adaptation studies should be established. This will increase both the quality of the studies and the comparability between different translations.
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